UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000047456
Receipt No. R000054115
Scientific Title Remote visual ADL investigation for retinitis pigmentosa
Date of disclosure of the study information 2022/04/11
Last modified on 2022/09/12 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Remote visual ADL investigation for retinitis pigmentosa
Acronym Re-RP LVFAM prototype
Scientific Title Remote visual ADL investigation for retinitis pigmentosa
Scientific Title:Acronym Re-RP LVFAM prototype
Region
Japan

Condition
Condition retinitis pigmentosa
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Tolerability study of the new LVFAM, a modified version of the Visual ADL Questionnaire (LVFAM) for retinitis pigmentosa (RP) and remote use.
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Tolerability Checklist
Key secondary outcomes

Base
Study type Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >
Gender Male and Female
Key inclusion criteria 1) Retinitis pigmentosa patients in the outpatient clinic of Chiba University Department of Ophthalmology
2) Visited between January 1, 2022 and September 30, 2022
3) History of Humphrey Field of View (HFA) 10-2 measurements
4) Corrected visual acuity in both eyes in the range of 0.2 to 0.9
Key exclusion criteria (1) 20 years of age or older and less than 80 years of age
(3) Patients with other ophthalmologic diseases that affect visual function
4) Cases of blindness in one eye
(5) Cases with significant fluctuations in visual function and findings
Target sample size 5

Research contact person
Name of lead principal investigator
1st name Takeshi
Middle name
Last name Sugawara
Organization Chiba University Hpspital
Division name Ophthalmology
Zip code 260-8677
Address Chiba City, Chuo-ku, Inohana 1-8-1
TEL 0432227171
Email takeshis@faculty.chiba-u.jp

Public contact
Name of contact person
1st name Takeshi
Middle name
Last name Sugawara
Organization Chiba University Hospital
Division name Ophthalmology
Zip code 260-8677
Address Chiba City, Chuo-ku, Inohana 1-8-1
TEL 0432227171
Homepage URL
Email takeshis@faculty.chiba-u.jp

Sponsor
Institute Chiba University Hospital
Institute
Department

Funding Source
Organization MEXT
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Chiba University Hospital
Address Chiba City, Chuo-ku, Inohana 1-8-1
Tel 0432227171
Email takeshis@faculty.chiba-u.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 04 Month 11 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2022 Year 02 Month 09 Day
Date of IRB
2022 Year 04 Month 01 Day
Anticipated trial start date
2022 Year 04 Month 11 Day
Last follow-up date
2022 Year 08 Month 09 Day
Date of closure to data entry
2022 Year 08 Month 10 Day
Date trial data considered complete
2022 Year 09 Month 12 Day
Date analysis concluded
2022 Year 09 Month 12 Day

Other
Other related information questionnaire survey

Management information
Registered date
2022 Year 04 Month 11 Day
Last modified on
2022 Year 09 Month 12 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054115